U.S. judge invalidates Acorda multiple sclerosis drug patents

(Reuters) – A federal judge in Delaware on Friday struck down key patents held by Acorda Therapeutics Inc related to its multiple sclerosis drug Ampyra, causing the stock to tumble 24 percent before trading was halted.

Leave a Reply

Your email address will not be published. Required fields are marked *